Drug: cancidas Quarter: 2016Q3
Total Records: 85 Number of Pages: 5
| DRUGNAME | PT | EventCount |
|---|---|---|
| CANCIDAS | Product use issue | 3 |
| CANCIDAS | Renal impairment | 3 |
| CANCIDAS | Septic shock | 3 |
| CANCIDAS | Actinic keratosis | 2 |
| CANCIDAS | Aspartate aminotransferase increased | 2 |
| CANCIDAS | Atypical mycobacterial infection | 2 |
| CANCIDAS | Blood alkaline phosphatase increased | 2 |
| CANCIDAS | Blood lactate dehydrogenase increased | 2 |
| CANCIDAS | C-reactive protein increased | 2 |
| CANCIDAS | Cardiac arrest | 2 |
| CANCIDAS | Cholecystitis acute | 2 |
| CANCIDAS | Drug eruption | 2 |
| CANCIDAS | Drug interaction | 2 |
| CANCIDAS | Drug reaction with eosinophilia and systemic symptoms | 2 |
| CANCIDAS | Dysplastic naevus | 2 |
| CANCIDAS | Epilepsy | 2 |
| CANCIDAS | Interstitial lung disease | 2 |
| CANCIDAS | Lymphoma | 2 |
| CANCIDAS | Photodermatosis | 2 |
| CANCIDAS | Photosensitivity reaction | 2 |
Total Records: 85 Number of Pages: 5